@article {Lisbonajrheum.130902, author = {Maria Pilar Lisbona and Anna P{\`a}mies and Jes{\'u}s Ares and Miriam Almirall and Maria Navallas and Albert Solano and Joan Maym{\'o}}, title = {Association of Bone Edema with the Progression of Bone Erosions Quantified by Hand Magnetic Resonance Imaging in Patients with Rheumatoid Arthritis in Remission}, elocation-id = {jrheum.130902}, year = {2014}, doi = {10.3899/jrheum.130902}, publisher = {The Journal of Rheumatology}, abstract = {Objective To evaluate the association of synovitis, bone marrow edema (BME), and tenosynovitis in the progression of erosions quantified by hand magnetic resonance imaging (MRI) at 1 year in patients with early rheumatoid arthritis (RA) in remission. Methods A total of 56 of 196 patients with early RA in remission at 1 year and with available MRI data at baseline and at 12 months were included. MRI images were assessed according to the Rheumatoid Arthritis Magnetic Resonance Imaging Scoring (RAMRIS) system. Persistent remission was defined as 28-joint Disease Activity Score-erythrocyte sedimentation rate <= 2.6 and/or Simplified Disease Activity Index <= 3.3 and/or the new boolean American College of Rheumatology/European League Against Rheumatism remission criteria for a continuous period of at least 6 months. Progression of bone erosions was defined as an increase of 1 or more units in annual RAMRIS score for erosions compared to baseline. Results At 1 year, the majority of patients with RA in sustained remission showed some inflammatory activity on MRI (94.6\% synovitis, 46.4\% BME, and 58.9\% tenosynovitis) and 19 of the 56 patients (33.9\%) showed MRI progression of bone erosions. A significant difference was observed in MRI BME at 1 year, with higher mean score in patients with progression compared to nonprogression of erosions (4.8 {\textpm} 5.6 and 1.4 {\textpm} 2.6, p = 0.03). Conclusion Subclinical inflammation was identified by MRI in 96.4\% of patients with RA in sustained clinical remission. Significantly higher scores of BME after sustained remission were observed in patients with progression of erosions compared to patients with no progression. The persistence of higher scores of BME may explain the progression of bone erosions in patients with persistent clinical remission.}, issn = {0315-162X}, URL = {https://www.jrheum.org/content/early/2014/06/25/jrheum.130902}, eprint = {https://www.jrheum.org/content/early/2014/06/25/jrheum.130902.full.pdf}, journal = {The Journal of Rheumatology} }